Officials from Kimberly-Clark said in the report that the acquisition would increase its medical devices sales by 50 percent and is part of the company’s strategy to move into “higher-growth, higher-margin medical devices.” Both companies have approved the deal and expect to close by the end of the fourth quarter.
Kimberly-Clark also bought privately held Baylis Medical Co. for an undisclosed price last week.
Kimberly-Clark’s healthcare division as the only one to register sales growth for the company, according to the report. Last year, the division had $1.22 billion in sales, and it is up 4.8 percent to $633 million for the first six months of 2009.
Read the WSJ’s report about Kimberly-Clark’s acquisition of I-Flow.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
